The Weekly Roundup: December 12-16

What to Expect at the 2022 Virtual RAD Conference

The Revolutionizing Atopic Dermatitis Conference takes place on December 11th, 2022.

Raj Chovatiya, MD, PhD, Discusses his Sessions at the Upcoming RAD Conference

Raj Chovatiya, MD, PhD, gives a preview of his discussions on topical formulations of atopic dermatitis and advancing therapeutic expectations at this weekend’s RAD conference.

Racial Differences of AD Characteristics in US Patients

A poster presentation from the 2022 RAD Conference analyzed manifestations of atopic dermatitis across racial groups.

How to Support Caregivers of Children with AD

A 2022 RAD Conference poster presentation explored how to better support caregivers of children with atopic dermatitis.

Effects of Omega-3 Fatty Acid Supplementation on Atopic Dermatitis

A 2022 RAD Conference poster presentation explores the efficacy of the therapy for the treatment or prevention of AD.

Boston Children’s Multidisciplinary Clinic’s Model for Adverse Mental Health Effects of AD

At the 2022 RAD Virtual Conference, a Harvard University psychologist discusses ways that practitioners can help identify and treat children with adverse mental health outcomes as a result of atopic dermatitis.

Onset of Atopic Comorbidities Relative to Atopic Dermatitis Diagnosis in a Real-World Setting Using an Israeli Claims Database

A 2022 RAD Conference abstract presentation showed the epidemiology of type 2 associated conditions included in patients with AD.

Study Limitations in Generalized Pustular Psoriasis

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss study limitations regarding health records in generalized pustular psoriasis and how the number of flares could be underestimated.

Impact of Data on Generalized Pustular Psoriasis

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.

The Shades of Atopic Dermatitis in Skin of Color

At the 2022 RAD virtual conference, a dermatologist examines treatment options for AD in various racial and ethnic groups.

Updates on Topical Therapy Treatment for AD

Jonathan Silverberg, MD, PhD, MPHS, gives an overview of topical therapies for atopic dermatitis at the 2022 virtual RAD conference.

Expert Perspectives on a Recent Approval in Acne Management

Hilary Baldwin, M.D., comments on the impact of the recent approval of clascoterone cream 1% in the topical acne armamentarium of patients suffering from acne.

Treatment Selection Considerations for Mild to Moderate Acne

Dr Hilary Baldwin discusses her treatment considerations and approach in the management of patients with mild to moderate acne, highlighting the benefit of combination therapy.

Unmet Needs and the Role of Consensus Guidelines in Acne Management

An expert in acne management shares her insight on the current needs and the role of consensus guidelines in the management of patients suffering from acne.

Future Directions and Practice Pearls for the Management of Acne

Hilary Baldwin, M.D., shares her hopes for the future of acne treatment and provides her practice pearls from a panel discussion surrounding the management of patients suffering from acne.

Digital Dermatology: Opportunities for Atopic Dermatitis

At the RAD 2022 Conference, Steve Xu, MD, MSc, explains how a wearable sensor can better track the progression of atopic dermatitis while a patient is sleeping.

The Growing Popularity of Growth Factors

In this month's Cosmetic Condundrums columns, Zoe Diana Draelos, MD, discussed growth factors for anti-aging.

Expert Perspectives on the Rapid Expansion of Atopic Dermatitis Treatments

Raj Chovatiya, MD, PhD, and Neal Bhatia, MD, share their thoughts on the clinical implications of the rapid expansion of the atopic dermatitis treatment armamentarium.

Atopic Dermatitis Treatment Biological Targets

Drs Raj Chovatiya and Neal Bhatia highlight the biological targets of current and emerging treatments for the management of atopic dermatitis and discuss the importance of safety and long-term data.

Peer Support for Eczema Caregivers

At the RAD 2022 Conference, Keri Kelley, Senior Outreach and Community Manager at Global Parents for Eczema Research discussed a program aimed at providing support for eczema caregivers.

Use of JAK Inhibitors in Clinical Practice

Experts in dermatology discuss the use of oral and topical JAK inhibitors in clinical practice and their reflection of overarching treatment guidelines and indications.

Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management

Raj Chovatiya, M.D., Ph.D. and Neal Bhatia, MD comment on the importance of assessing a treatment’s available clinical trial data, ability to control disease severity, and QoL impacts when assessing atopic dermatitis treatment options.

Final Thoughts for Atopic Dermatitis Treatment

Drs Raj Chovatiya and Neal Bhatia summarize their final thoughts on the available treatment options for the management of atopic dermatitis.

Emerging Therapies to Manage Vitiligo

Nada Elbuluk, MD, and David Rosmarin, MD, share their thoughts on future treatments in the pipeline for vitiligo.

Advice for Treating Vitiligo

Nada Elbuluk, MD, and David Rosmarin, MD, provide advice to physicians on the management of vitiligo.

Hydrinity Accelerated Skin Science Launches New Skin Care Line

Hyaluronic acid is the superhero ingredient of this new skin care line.

Choosing the Right Financial Adviser: A Fundamental Decision for Long-Term Financial Security

Choosing an investment adviser can be an extremely important decision for the long-term financial security of any clinician.

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

In this episode, Christopher Bunick, MD, PhD, discusses a paper he recently co-authored, which explores JAK inhibitor safety compared to traditional systemic therapies for atopic dermatitis.

Immunomic Therapeutics Receives Fast Track Designation for Rare Skin Cancer Vaccine

The PharmaJet Stratis Needle-free Injection System’s vaccine could help prevent a rare but aggressive form of skin cancer.

Recap of the 2022 RAD Conference

Catch up on coverage from the 2022 Revolutionizing Atopic Dermatitis Conference.

Evidence Based Treatment Options for Plaque Psoriasis

Linda Stein Gold, MD, and Jennifer Soung, MD, provide an overview of the different, evidence-based topical strategies for treating plaque psoriasis.

Roflumilast: Plaque Psoriasis Phase III Trial Overview

Jennifer Soung, MD, provides an overview of the phase III trials, DERMIS-1/DERMIS-2, in which roflumilast was used to treat plaque psoriasis.

FDA Approves Adalimumab-aacf for Plaque Psoriasis, Hidradenitis Suppurativa and Other Conditions

A biologic from Germany offers a new treatment option for a number of dermatologic conditions.

All You Need to Know About Back Acne

Truncal acne, or back acne, is a common skin condition of the pilosebaceous unit, with a global lifetime prevalence of 70% to 85%.

Update on the Genetics of Vitiligo

Vitiligo can have a profound effect on mental health and quality of life.

Holistic Treatment for the Management of Atopic Dermatitis

Patients are finding relief in alternative therapy for the chronic skin disease.

Blastic Plasmacytoid Dendritic Cell Neoplasm in Children, Adolescents, and Young Adults

Whether occurring in the adult or pediatric population, the diagnosis of blastic plasmacytoid dendritic cell neoplasm is challenging to make and carries a poor prognosis.

Treatment of Vitiligo with Phototherapy

Phototherapy can serve an important role in the therapeutic armamentarium of vitiligo as it is safe, cost-effective, and can treat patients with large areas of disease.